Back to search
FDAFDA · Food and drugs·Recall number D-0639-2022

Olanzapine Tablets, USP 10 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA , Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, HImachal Pradesh, India, NDC 33342-070-07.

Published March 9, 2022 · Recall initiated: February 16, 2022

Summary

FDA records drug Class II recall D-0639-2022, published March 9, 2022 and initiated February 16, 2022. Recalling firm: Macleods Pharma Usa Inc; Status: Terminated; Reported quantity: 3672 bottles; Lot: Lot #: BOB42029A, BOB4202B, Exp. Date 09/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGmp Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email if OLANZAPINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
OLANZAPINE
Manufacturer
Macleods Pharma Usa Inc
Distributor
Nationwide within the United States
UPC
0333342067074
Lot
Lot #: BOB42029A, BOB4202B, Exp. Date 09/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Olanzapine Tablets, USP 10 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA , Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, HImachal Pradesh, India, NDC 33342-070-07. recalled?

Yes. FDA published recall D-0639-2022 on March 9, 2022. Reported hazard: cGmp Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: OLANZAPINE. UPC: 0333342067074.